Limosone-NM Cream is a topical formulation combining Clobetasol propionate (0.05% w/w), Miconazole nitrate (2% w/w), and Neomycin sulfate (0.5% w/w), designed for the management of inflammatory and infectious dermatological conditions. Clobetasol, a potent corticosteroid, exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects, effectively reducing erythema, swelling, and itching associated with various dermatoses. Miconazole, an imidazole antifungal agent, inhibits the synthesis of ergosterol, a vital component of fungal cell membranes, thereby exhibiting broad-spectrum antifungal activity against dermatophytes, yeasts, and molds. Neomycin, an aminoglycoside antibiotic, provides antibacterial coverage primarily against gram-negative organisms by inhibiting bacterial protein synthesis. The combination in Limosone-NM Cream is particularly beneficial in treating mixed infections where inflammation, fungal, and bacterial components coexist, such as in complicated eczema, intertrigo, and secondary infected fungal infections. It is intended for topical use only and should be applied sparingly to the affected area as prescribed by a healthcare professional. Prolonged use or application over large body surfaces should be avoided to minimize systemic absorption and potential adverse effects. Patients should be advised to discontinue use if irritation or hypersensitivity occurs and to consult a physician for appropriate diagnosis and treatment guidance.